CW August 2003
Volume 12Issue Number 8 August 2003 ISSN 10593802 Third-Line Treatment for Metastatic Colorectal Cancer With FOLFOX4A regimen previously shown to have activity in first-line and salvage treatment of metastatic colorectal cancer also has activity in patients who have progressed after standard second-line treatment has failed.
Go to Previous Page Go to Next Page Source & Additional Reading N. E. Kemeny, 39th Annual Meeting of the American Association of Clinical Oncology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW August 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
